Related references
Note: Only part of the references are listed.Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
Manli Wang et al.
CELL RESEARCH (2020)
Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology
Eva Schrezenmeier et al.
NATURE REVIEWS RHEUMATOLOGY (2020)
New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?
Christian A. Devaux et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
Philippe Gautret et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Cytokine release syndrome in severe COVID-19
John B. Moore et al.
SCIENCE (2020)
Can cell therapies halt cytokine storm in severe COVID-19 patients?
James Ankrum
Science Translational Medicine (2020)
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
David E. Gordon et al.
NATURE (2020)
Association of Hydroxychloroquine With QTc Interval in Patients With COVID-19
Andrea Mazzanti et al.
CIRCULATION (2020)
Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia
Sara De Biasi et al.
NATURE COMMUNICATIONS (2020)
Role of Chemokine Receptor CCR4 and Regulatory T Cells in Wound Healing of Diabetic Mice
Janaina F. Barros et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2019)
Immunosuppressive effects of hydroxychloroquine and artemisinin combination therapy via the nuclear factor-κB signaling pathway in lupus nephritis mice
Ning Liang et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2018)
Signaling and Function of Interleukin-2 in T Lymphocytes
Sarah H. Ross et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 36 (2018)
Interleukin-7 restores lymphocytes in septic shock: the IRIS-7 randomized clinical trial
Bruno Francois et al.
JCI INSIGHT (2018)
A comprehensive map of molecular drug targets
Rita Santos et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
CCR4 is a determinant of melanoma brain metastasis
Anat Klein et al.
ONCOTARGET (2017)
Improving Antibody-Based Cancer Therapeutics Through Glycan Engineering
Xiaojie Yu et al.
BIODRUGS (2017)
2,8-Diazaspiro[4.5]decan-8-yl)pyrimidin-4-amine potent CCR4 antagonists capable of inducing receptor endocytosis
Lena Shukla et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Janus kinase (JAK) inhibitors in the treatment of inflammatory and neoplastic diseases
Robert Roskoski
PHARMACOLOGICAL RESEARCH (2016)
Improving chemical similarity ensemble approach in target prediction
Zhonghua Wang et al.
JOURNAL OF CHEMINFORMATICS (2016)
Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases
K. D. Rainsford et al.
INFLAMMOPHARMACOLOGY (2015)
Immune-Induced Fever Is Mediated by IL-6 Receptors on Brain Endothelial Cells Coupled to STAT3-Dependent Induction of Brain Endothelial Prostaglandin Synthesis
Anna Eskilsson et al.
JOURNAL OF NEUROSCIENCE (2014)
The role of CXCL10 in the pathogenesis of experimental septic shock
Daniela S. Herzig et al.
CRITICAL CARE (2014)
Internalization of CCR4 and Inhibition of Chemotaxis by K777, a Potent and Selective CCR4 Antagonist
Takashi Sato et al.
PHARMACOLOGY (2013)
BACTERIAL CLEARANCE IN SEPTIC MICE IS MODULATED BY MCP-1/CCL2 AND NITRIC OXIDE
Rachel N. Gomes et al.
SHOCK (2013)
The Use of Infliximab to Control Recurrent Cytokine Storms in EBV-Associated Angioimmunoblastic Lymphoma and Hemophagocytic Syndrome
Sameh Gaballa et al.
BLOOD (2012)
Ganodermycin, a novel inhibitor of CXCL10 expression from Ganoderma applanatum
Mathias Jung et al.
JOURNAL OF ANTIBIOTICS (2011)
SwissDock, a protein-small molecule docking web service based on EADock DSS
Aurelien Grosdidier et al.
NUCLEIC ACIDS RESEARCH (2011)
Different host cell proteases activate the SARS-coronavirus spike-protein for cell-cell and virus-cell fusion
Graham Simmons et al.
VIROLOGY (2011)
IL-1 pathways in inflammation and human diseases
Cem Gabay et al.
NATURE REVIEWS RHEUMATOLOGY (2010)
Atorvastatin Reduces Plasma Levels of Chemokine (CXCL10) in Patients with Crohn's Disease
Olof Grip et al.
PLOS ONE (2009)
Detrimental Role of CC Chemokine Receptor 4 in Murine Polymicrobial Sepsis
Tobias Traeger et al.
INFECTION AND IMMUNITY (2008)
In silico identified CCR4 antagonists target regulatory T cells and exert adjuvant activity in vaccination
Jagadeesh Bayry et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Recycling of chloroquine and its hydroxyl analogue to face bacterial, fungal and viral infections in the 21st century
Jean-Marc Rolain et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2007)
EADock: Docking of small molecules into protein active sites with a multiobjective evolutionary optimization
Aurelien Grosdidier et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2007)
Relating protein pharmacology by ligand chemistry
Michael J. Keiser et al.
NATURE BIOTECHNOLOGY (2007)
Role of the chemokine receptor CCR4 and its ligand thymus- and activation-regulated chemokine/CCL17 for lymphocyte recruitment in cutaneous lupus erythematosus
J Wenzel et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2005)
Chloroquine is a potent inhibitor of SARS coronavirus infection and spread
Martin J. Vincent et al.
VIROLOGY JOURNAL (2005)
Antibiotic susceptibility of Tropheryma whipplei in MRC5 cells
A Boulos et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Increased CCR4 expression on circulating CD4+ T cells in ankylosing spondylitis, rheumatoid arthritis and systemic lupus erythematosus
PT Yang et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2004)
UCSF chimera - A visualization system for exploratory research and analysis
EF Pettersen et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2004)
Interleukin-10 controls the onset of irreversible septic shock
SQ Latifi et al.
INFECTION AND IMMUNITY (2002)
Share Paper
